Hinman Samuel S, Kim Raehyun, Wang Yuli, Phillips K Scott, Attayek Peter J, Allbritton Nancy L
Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, and North Carolina State University, Raleigh, NC 27607, USA.
Curr Opin Biomed Eng. 2020 Mar;13:94-102. doi: 10.1016/j.cobme.2019.12.010. Epub 2020 Jan 3.
Design parameters for microphysiological systems (MPS) are driven by the need for new tools to answer questions focusing on human physiology in a robust and reliable manner. Within this perspective, engineering benchmarks and principles are identified to guide the construction of new devices in the MPS field, with emphasis placed on the design principles common to all tissues, as well as those unique to a subset of tissues. Leading organ replica technologies that recapitulate various functions of the brain, heart, intestine, and lung are highlighted as examples that meet the identified benchmarks and standards, with current barriers for large scale production and commercialization discussed. To reach their full potential and achieve widespread use, MPS will have to be recognized officially by government agencies, and toward this end, considerations of MPS as a potential regulatory tool are presented.
微生理系统(MPS)的设计参数是由对新工具的需求驱动的,这些新工具需要以稳健且可靠的方式回答聚焦于人体生理学的问题。从这个角度出发,确定了工程基准和原则,以指导MPS领域新设备的构建,重点放在所有组织共有的设计原则以及特定组织子集所特有的设计原则上。作为符合已确定基准和标准的示例,突出介绍了能够重现大脑、心脏、肠道和肺部各种功能的领先器官复制技术,并讨论了当前大规模生产和商业化的障碍。为了充分发挥其潜力并实现广泛应用,MPS必须得到政府机构的正式认可,为此,还介绍了将MPS视为潜在监管工具的相关考量。